Valuation
- Market cap
- 234,000
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 1,400
- Avg volume
- 12,552
- Day's range
- $0.22 – $0.44
- Shares out
- 1,062,000
- Stochastic %K
- 34%
- Beta
- 1.19
- Analysts
- —
- Price target
- —
Company profile
Biomolecular Life Holdings, Inc. develops and sells wellness and longevity technology products in the United States. It offers products, such as premium supplements developed using nutrigenomics and artificial intelligence; services, including biomolecular science, precision nutrition, and regenerative wellness technologies. The company was formerly known as SB Technology Holdings Inc. and changed its name to Biomole...
Show more
Biomolecular Life Holdings, Inc. develops and sells wellness and longevity technology products in the United States. It offers products, such as premium supplements developed using nutrigenomics and artificial intelligence; services, including biomolecular science, precision nutrition, and regenerative wellness technologies. The company was formerly known as SB Technology Holdings Inc. and changed its name to Biomolecular Life Holdings, Inc. in July 2026. The company is based in Miami, Florida. Biomolecular Life Holdings, Inc. operates as a subsidiary of KH Feelux Co., Ltd.
- Industry
- Shell Companies
- Sector
- Financial Services
- Phone
- 424 224 5358
- Website
- https://www.vglscorp.com
- Address
- 447 Broadway, 2nd Floor, Unit 103, New York, United States
Latest news
No headlines yet.
